What is Healthspan?
While lifespan refers to the total number of years you live, healthspan refers to the number of those years that you are healthy and free from chronic disease. The goal of longevity science is not just to add years to your life, but life to your years. This guide delves into the evidence-based strategies that can help you extend your healthspan.
The distinction between lifespan and healthspan is critical. Global average life expectancy has risen dramatically over the past century, reaching approximately 73.4 years as of 2023 according to the World Health Organization. However, the World Health Organization also estimates that the global healthy life expectancy (HALE) is only about 63.3 years. That means the average person spends roughly the last decade of their life managing one or more chronic conditions such as cardiovascular disease, type 2 diabetes, cancer, or neurodegenerative disorders.
As Kaeberlein noted in his 2018 paper in GeroScience, the healthspan concept is valuable precisely because it reframes aging research away from simply preventing death and toward preserving functional capacity and quality of life. Rather than asking "How long can we live?" the more meaningful question becomes "How long can we live well?"
In practical terms, closing the gap between lifespan and healthspan means compressing morbidity — pushing the onset of chronic disease closer to the end of life so that the period of decline is as short as possible. This concept, first proposed by James Fries in 1980, remains the central ambition of modern longevity science.
Written by: Vik Chadha, Founder of Finding Answers To. Content is regularly reviewed and updated based on the latest peer-reviewed research.
The Hallmarks of Aging
In 2013, researchers Carlos Lopez-Otin, Maria Blasco, Linda Partridge, Manuel Serrano, and Guido Kroemer published a landmark paper identifying nine hallmarks of aging. In their 2023 update published in Cell, they expanded this framework to twelve hallmarks, reflecting advances in our understanding of the aging process (Lopez-Otin et al., 2023). These hallmarks represent the fundamental biological mechanisms that drive aging at the molecular and cellular level.
Understanding these hallmarks is essential because virtually every intervention in longevity science targets one or more of them. Here are all twelve:
Genomic Instability: Over time, both external factors (UV radiation, toxins) and internal processes (replication errors, reactive oxygen species) cause accumulating DNA damage. While repair mechanisms exist, they become less efficient with age, leading to mutations that can drive cancer and cellular dysfunction.
Telomere Attrition: Telomeres are protective caps at the ends of chromosomes that shorten with each cell division. When telomeres become critically short, cells enter senescence or apoptosis. Telomere length is widely studied as a biomarker of biological age.
Epigenetic Alterations: Aging is accompanied by changes in DNA methylation patterns, histone modifications, and chromatin remodeling. These epigenetic changes alter gene expression without changing the DNA sequence itself and are now the basis for biological age clocks such as the Horvath clock.
Loss of Proteostasis: Cells rely on a network of quality-control mechanisms to maintain properly folded, functional proteins. With age, this proteostasis network deteriorates, leading to the accumulation of misfolded or aggregated proteins — a hallmark of diseases like Alzheimer's and Parkinson's.
Deregulated Nutrient Sensing: Pathways such as mTOR, AMPK, sirtuins, and insulin/IGF-1 signaling regulate how cells respond to nutrient availability. With age, these pathways become dysregulated, promoting growth-oriented signaling even when the body would benefit from repair and maintenance modes.
Mitochondrial Dysfunction: Mitochondria are the energy-producing organelles in cells. With age, mitochondrial function declines, leading to reduced energy production, increased reactive oxygen species generation, and impaired cellular metabolism. NAD+ depletion is closely linked to this hallmark.
Cellular Senescence: Senescent cells permanently stop dividing but resist apoptosis, accumulating in tissues over time. They secrete a cocktail of inflammatory molecules known as the senescence-associated secretory phenotype (SASP), which damages surrounding healthy tissue. Learn more in our guide to senolytics and how they work.
Stem Cell Exhaustion: Adult stem cells are responsible for tissue repair and regeneration. With age, stem cell populations decline in number and function, reducing the body's capacity to heal and maintain tissues. This manifests as slower wound healing, reduced immune function, and loss of muscle mass.
Altered Intercellular Communication: Aging disrupts signaling between cells, including neuroendocrine, hormonal, and immune system communication. This leads to a pro-inflammatory tissue environment and impairs the coordinated function of organ systems.
Disabled Macroautophagy: Autophagy is the cellular recycling process that clears damaged organelles and misfolded proteins. When autophagy declines with age, cellular waste accumulates and contributes to dysfunction. For a deeper exploration, see our article on the role of autophagy in cellular health.
Chronic Inflammation: Often referred to as "inflammaging," this low-grade, persistent inflammation increases with age and is driven by factors like senescent cell accumulation, gut barrier dysfunction, and immune system changes. Chronic inflammation is a major driver of heart disease, cancer, and neurodegeneration.
Dysbiosis: The gut microbiome changes significantly with age, often shifting toward a less diverse, more inflammatory composition. This microbial imbalance contributes to systemic inflammation, impaired nutrient absorption, and weakened immune function. Research increasingly links gut health to brain health, cardiovascular function, and overall longevity.
These twelve hallmarks are deeply interconnected. For example, mitochondrial dysfunction generates reactive oxygen species that accelerate genomic instability, while cellular senescence drives chronic inflammation, which in turn impairs stem cell function. Effective longevity interventions often target multiple hallmarks simultaneously.
Key Interventions Backed by Research
While there is no single "fountain of youth," several interventions have demonstrated meaningful effects on aging in laboratory studies and, in some cases, in human trials. Below are the most well-studied strategies currently being investigated.
Caloric Restriction and Intermittent Fasting
Caloric restriction (CR) — reducing calorie intake by 15-40% without malnutrition — is the most consistently replicated longevity intervention in animal models. CR has been shown to extend lifespan in yeast, worms, flies, and rodents. In rhesus monkeys, a 20-year study at the University of Wisconsin demonstrated that CR reduced the incidence of age-related diseases including diabetes, cancer, and cardiovascular disease.
In humans, the CALERIE trial (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) found that even a modest 12% caloric reduction over two years improved cardiometabolic risk factors and reduced markers of biological aging. As Fontana and Partridge discussed in their 2015 Cell review, the mechanisms likely involve activation of nutrient-sensing pathways such as AMPK and sirtuins, reduced mTOR signaling, and enhanced autophagy.
Intermittent fasting (IF) offers a more practical alternative to continuous caloric restriction. De Cabo and Mattson, writing in the New England Journal of Medicine in 2019, reviewed evidence that time-restricted eating and periodic fasting trigger many of the same metabolic switches as CR, including improved insulin sensitivity, reduced inflammation, and enhanced cellular repair processes. Common approaches include 16:8 time-restricted eating and 5:2 fasting protocols.
Rapamycin and mTOR Inhibition
Rapamycin, originally developed as an immunosuppressant, is the only drug consistently shown to extend lifespan in mice when administered later in life. It works by inhibiting mTOR (mechanistic target of rapamycin), a nutrient-sensing pathway that promotes cell growth. When mTOR is active, it suppresses autophagy and other maintenance processes. By inhibiting mTOR, rapamycin shifts cells toward a repair-and-recycle mode.
The Interventions Testing Program (ITP), a rigorous NIH-funded study, found that rapamycin extended median lifespan in mice by 9-14%, even when treatment started at 20 months of age (roughly equivalent to 60 human years). Clinical trials are now underway to evaluate low-dose rapamycin in humans for age-related conditions. For a comprehensive discussion, see our complete guide to rapamycin for longevity.
Metformin
Metformin, a widely prescribed diabetes medication, has attracted attention as a potential longevity drug after observational studies showed that diabetic patients taking metformin had lower all-cause mortality than non-diabetic controls. Metformin activates AMPK, improves insulin sensitivity, reduces inflammation, and may inhibit mTOR signaling. The TAME (Targeting Aging with Metformin) trial, led by Nir Barzilai at the Albert Einstein College of Medicine, is the first FDA-approved clinical trial specifically designed to test whether a drug can slow aging in humans.
NAD+ Precursors (NMN and NR)
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme essential for energy metabolism, DNA repair, and sirtuin activity. NAD+ levels decline significantly with age — by as much as 50% between the ages of 40 and 60 in some tissues. This decline is associated with mitochondrial dysfunction, impaired DNA repair, and metabolic disorders.
Two main precursors are used to boost NAD+ levels: nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). David Sinclair's research at Harvard has shown that NMN supplementation in mice restores NAD+ levels and reverses age-related declines in mitochondrial function, blood vessel health, and exercise capacity. Human trials are still in early stages, but initial results suggest that both NMN and NR can safely elevate blood NAD+ levels. We compare these two precursors in detail in our article on NMN vs. NR: which NAD+ precursor is best.
Senolytics
Senolytic drugs selectively clear senescent cells — the "zombie cells" that accumulate with age and drive chronic inflammation. The most studied senolytic combination is dasatinib plus quercetin (D+Q), which was shown in mouse studies at the Mayo Clinic to extend healthspan, reduce frailty, and improve cardiovascular function. Fisetin, a flavonoid found in strawberries, has also demonstrated senolytic properties in preclinical models. Human clinical trials for senolytic therapies are actively underway. For a complete overview, visit our guide on what senolytics are and whether they work.
Exercise
Of all known interventions, regular physical exercise has the most robust and consistent evidence for extending both lifespan and healthspan in humans. A large meta-analysis published in the British Medical Journal found that meeting the WHO recommended activity guidelines (150 minutes of moderate or 75 minutes of vigorous exercise per week) was associated with a 31% reduction in all-cause mortality. The mechanisms are extensive: exercise reduces inflammation, improves mitochondrial function, enhances autophagy, maintains muscle mass, improves insulin sensitivity, and supports cardiovascular and brain health.
Sleep Optimization
Sleep is a critical but often underappreciated pillar of longevity. During deep sleep (slow-wave sleep), the brain activates its glymphatic system to clear metabolic waste, including amyloid-beta proteins linked to Alzheimer's disease. Sleep deprivation accelerates cellular aging, increases inflammation, impairs glucose metabolism, and raises the risk of cardiovascular disease. Adults who consistently sleep fewer than 6 hours per night have significantly elevated mortality risk compared to those sleeping 7-8 hours. For science-backed strategies, see our guide on how to improve deep sleep scientifically.
The Role of Diet and Exercise
While pharmacological interventions are promising, the foundation of any longevity strategy remains diet and exercise. These two factors are modifiable, accessible, and supported by the strongest body of human evidence.
The Mediterranean Diet and Longevity
The Mediterranean diet — rich in olive oil, vegetables, fruits, legumes, whole grains, fish, and moderate red wine — is the most studied dietary pattern in longevity research. The PREDIMED trial, a large randomized controlled trial involving over 7,400 participants, found that a Mediterranean diet supplemented with extra-virgin olive oil or mixed nuts reduced the incidence of major cardiovascular events by approximately 30% compared to a control diet.
Studies of Blue Zones — regions where people live the longest, including Sardinia (Italy), Okinawa (Japan), and Loma Linda (California) — reveal dietary patterns that share features with the Mediterranean diet: primarily plant-based, rich in legumes, low in processed foods, and moderate in calorie intake. These populations also tend to eat until they are about 80% full, a practice that naturally mimics mild caloric restriction.
Zone 2 Training
Zone 2 training refers to low-intensity aerobic exercise performed at a heart rate where you can still hold a conversation, typically 60-70% of maximum heart rate. This intensity preferentially uses fat as fuel and targets mitochondrial function in type I (slow-twitch) muscle fibers. Longevity physician Peter Attia has popularized zone 2 training as the single most important exercise modality for metabolic health and longevity.
At the cellular level, zone 2 training stimulates mitochondrial biogenesis, improves fat oxidation, enhances lactate clearance, and increases the efficiency of oxidative phosphorylation. Research suggests that 3-4 sessions of 45-60 minutes of zone 2 cardio per week can meaningfully improve metabolic health, reduce insulin resistance, and lower the risk of type 2 diabetes and cardiovascular disease.
Resistance Training and Muscle Mass
Sarcopenia — the age-related loss of muscle mass and strength — begins as early as the third decade of life and accelerates after age 60. Loss of muscle mass is associated with increased falls, fractures, metabolic dysfunction, and mortality. Resistance training is the most effective countermeasure.
Beyond preserving muscle mass, resistance training improves bone density, enhances insulin sensitivity, reduces visceral fat, and stimulates the release of myokines — signaling molecules from muscles that have anti-inflammatory and neuroprotective effects. A comprehensive longevity exercise program should include both zone 2 cardio and resistance training at least 2-3 times per week.
Biomarkers of Aging
One of the most significant advances in longevity science has been the development of tools to measure biological age — how old your body is at the cellular level, which can differ substantially from chronological age. These biomarkers allow researchers and individuals to track the pace of aging and evaluate whether interventions are working.
Epigenetic Clocks
Epigenetic clocks, such as the Horvath clock (2013) and GrimAge, estimate biological age based on DNA methylation patterns at specific sites across the genome. These clocks have been validated in large cohort studies and can predict mortality risk independently of chronological age. The newer DunedinPACE clock goes further by measuring the pace of aging rather than a static biological age, making it useful for evaluating short-term interventions.
Blood Biomarkers
Several blood-based biomarkers are associated with aging and can be tracked over time:
- hsCRP (high-sensitivity C-reactive protein): A marker of systemic inflammation strongly associated with cardiovascular risk and overall mortality.
- Fasting insulin and glucose (HOMA-IR): Indicators of metabolic health and insulin resistance, a key driver of age-related disease.
- ApoB: A measure of atherogenic lipoprotein particles, increasingly viewed as a more accurate cardiovascular risk marker than LDL cholesterol alone.
- HbA1c: Reflects average blood glucose over 2-3 months and is associated with diabetes risk and glycation-related aging.
- Cystatin C: A more accurate marker of kidney function than creatinine, particularly in older adults.
- GDF-15: Emerging as a powerful biomarker of biological aging and mitochondrial stress.
Functional Tests
Beyond lab tests, functional assessments provide practical insight into biological age and resilience:
- VO2 max: Cardiorespiratory fitness is one of the strongest predictors of all-cause mortality. Individuals in the top quartile of VO2 max for their age have roughly a 5x survival advantage over those in the bottom quartile.
- Grip strength: A simple but powerful predictor of mortality, disability, and cardiovascular events in older adults.
- Sit-to-stand test: The ability to rise from the floor without using hands correlates with musculoskeletal fitness and mortality risk.
- DEXA scan: Dual-energy X-ray absorptiometry measures body composition (lean mass, fat mass, bone density), providing a detailed picture of sarcopenia and osteoporosis risk.
Frequently Asked Questions About Longevity
What is the difference between lifespan and healthspan?
Lifespan is the total number of years a person lives. Healthspan is the subset of those years spent in good health, free from chronic disease and significant disability. The average gap between the two is roughly 9-10 years globally, meaning most people spend the last decade of life in declining health. Longevity science focuses on closing this gap by delaying the onset of age-related disease.
Is it possible to reverse aging?
Partial age reversal has been demonstrated in animal models. Yamanaka factor reprogramming can reset epigenetic markers in cells to a younger state, and interventions like rapamycin, NAD+ precursors, and senolytics have reversed specific age-related declines in mice. In humans, some lifestyle interventions have been shown to reduce biological age as measured by epigenetic clocks. However, comprehensive age reversal in humans remains a research frontier, not a clinical reality.
What is the most impactful thing I can do right now for longevity?
The highest-impact interventions with the strongest human evidence are regular exercise (both cardiovascular and resistance training), maintaining a healthy body composition, not smoking, moderating alcohol intake, sleeping 7-8 hours per night, and following a nutrient-dense diet such as the Mediterranean diet. These lifestyle factors alone can reduce all-cause mortality risk by 60-80% compared to sedentary, unhealthy lifestyles.
Should I take longevity supplements like NMN, resveratrol, or rapamycin?
While preclinical evidence for several compounds is promising, most longevity supplements lack large-scale, long-term human clinical trial data. NMN and NR have shown they can raise NAD+ levels in humans, but their effect on hard health outcomes remains unproven. Rapamycin is a prescription drug with known side effects and should only be considered under medical supervision. Metformin is well-studied and relatively safe but has not yet been proven to slow aging in non-diabetics. Always consult a physician before starting any supplement or off-label drug regimen.
How can I measure my biological age?
Several commercial tests now estimate biological age. Epigenetic clock tests (such as TruDiagnostic and GrimAge) analyze DNA methylation from a blood sample. Blood biomarker panels measuring inflammatory markers, metabolic health, and organ function can also provide an age estimate. Functional tests like VO2 max, grip strength, and body composition (DEXA) offer practical, complementary measures of how well your body is aging.
References
- Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278.
- Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. 2015;161(1):106-118.
- de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381(26):2541-2551.
- Sinclair DA, LaPlante MD. Lifespan: Why We Age and Why We Don't Have To. Atria Books. 2019.
- Kaeberlein M. How healthy is the healthspan concept? GeroScience. 2018;40(4):361-364.
- Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res Rev. 2017;39:46-58.